ACE-PAS (ASSURE WCD Clinical Evaluation Post-Approval Study)
Real-world evidence generation for ASSURE WCD performance and safety
Key Facts
About Kestra Medical Technologies
Kestra Medical Technologies is a private medical device company commercializing the ASSURE® Cardiac Recovery System, a modern wearable cardioverter defibrillator (WCD) integrated with a digital health platform. Founded in 2014 and headquartered in Kirkland, Washington, the company targets the significant market of heart failure patients with low ejection fraction who are at elevated risk of sudden cardiac arrest during a vulnerable recovery period. Kestra differentiates its platform through a patient-centric design philosophy, remote patient data management via the Kestra CareStation™, and real-world clinical evidence from studies like the ACE-PAS trial. The company operates in the competitive cardiac rhythm management space but leverages connectivity and data to improve patient compliance and clinical oversight.
View full company profile